Kala Pharmaceuticals Announces Name Change To KALA BIO, Effective August 2, 2023
Portfolio Pulse from Happy Mohamed
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) has announced that it will change its name to KALA BIO, Inc. effective August 2, 2023. The name change reflects the company's focus on advancing biologics for the treatment of ophthalmic conditions. The company's common stock will continue to be listed on The Nasdaq Capital Market under the ticker symbol 'KALA'.
August 04, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Kala Pharmaceuticals is changing its name to KALA BIO, reflecting its focus on ophthalmic conditions. The stock will continue to trade under the symbol 'KALA'.
The name change reflects the company's strategic focus on ophthalmic conditions, which could potentially attract investors interested in this specific field. However, as the ticker symbol remains the same, the immediate impact on the stock price is likely to be neutral.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100